Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A new collaborative study between the Catalan Institute of Health, the Public Health Secreatariat of Catalonia, and the Centre for Statistics in Medicine (Nuffield Department of Orthopaedics, Rheumatology & Musculoskeletal Sciences) have confirmed that COVID-19 vaccines greatly reduce infections, hospitalisations and mortality for up to 6 months.

COVID-19 treatments in care homes

The study included almost 30,000 highly vulnerable nursing home residents who were under-represented in previous clinical trials. In addition, more than 26,000 nursing home staff and over 60,000 healthcare workers were studied, with reductions in infections comparable to those seen in nursing home residents.

“This study confirms the great value of the ongoing vaccination programmes to reduce COVID-19 transmission and the related healthcare burden and mortality,” said Dr Carmen Cabezas, Health Secretary for Catalonia. “Our strategy to vaccinate those most at risk first has proven valuable to reduce the impact of COVID-19 on those most likely to suffer severe forms of the disease. In addition, our plan to prioritise those most exposed to the virus, including our healthcare workers, has also proven useful to keep patients and staff safe whilst they care for us.  

Dr Prieto-Alhambra, Professor of Pharmacoepidemiology at Nuffield Department of Orthopaedics, Rheumatology & Musculoskeletal Sciences (University of Oxford) and senior author said: “We are collaborating internationally to produce solid evidence on the risk-benefit of COVID vaccines. Linked real world data from Catalonia and other parts of the world is being used for the study of the safety of vaccines. Here, we used linked primary care, hospital, vaccine, and laboratory data from Catalonia to expand our knowledge on their effectiveness in special subpopulations. The observed effects were in line with those seen in previous clinical trials.”  

Read the full story on the Nuffield Department of Orthopaedics, Rheumatology & Musculoskeletal Sciences website.

Similar stories

New computational technique reveals changes to lung function post COVID-19 infection

A new study led by Oxford researchers found that prior COVID-19 infection was associated with more uneven inflation of the lungs during normal breathing, smaller lung volumes, and greater respiratory dead space.

Oxford spinout Optellum secures $14m funding to advance pioneering AI-powered lung cancer diagnosis technology

Optellum, a University of Oxford spinout that provides a breakthrough AI platform to diagnose and treat early-stage lung cancer, has raised $14 million in a Series A funding round.

Celebrating Childhood Cancer Awareness Month

September was Childhood Cancer Awareness Month, and researchers in Department of Paediatrics took action to help raise awareness for this cause.

New study shows higher rate of fractures in people with intellectual disability

In the most comprehensive study of its kind, researchers at the University of Oxford and Oxford Health NHS Foundation Trust found a substantially higher rate of fractures in people with intellectual disability compared with people of the same age and gender without an intellectual disability.

New evidence for how our brains handle surprise

A new study from the Bruno Group is challenging our perceptions of how the different regions of the cerebral cortex function. A group of ‘quiet’ cells in the somatosensory cortex that rarely respond to touch have been found to react mainly to surprising circumstances. The results suggest their function is not necessarily driven by touch, but may indicate an important and previously unidentified role across all the major cortices.